Submission Deadline Extended to Dec. 19: AACR June L. Biedler Prize for Cancer Journalism
Cash Prize of $5,000 in Each of the Six Categories PHILADELPHIA – The submission deadline for the American Association...
Search/Filter
Loading...
AACR Mourns the Loss of Charles A. Coltman Jr., Cofounder of the San Antonio Breast Cancer Symposium
Charles A. Coltman Jr., MD, a cofounder of the San Antonio Breast Cancer Symposium (SABCS) and a longtime member...
Exercise Performed During Adjuvant Breast Cancer Treatment May Improve Cardiovascular Function
SAN ANTONIO – Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better...
Lifestyle Intervention Helped Breast Cancer Survivors Lose Weight, and Was Associated with Higher Disease-free Survival Rates
SAN ANTONIO – Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost weight...
Oxybutynin Decreased Frequency of Hot Flashes, Improved Quality of Life for Breast Cancer Survivors
SAN ANTONIO – Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could...
Choice of Surgery May Affect Quality of Life for Young Breast Cancer Survivors
SAN ANTONIO: Younger breast cancer patients who underwent mastectomy reported lower breast satisfaction and poorer psychosocial and sexual well-being...
Black Women Have Worse Breast Cancer Outcomes Despite Receiving Similar Treatment as White Women
SAN ANTONIO – Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly...
Liquid Biopsies in SOLAR-1 Trial Predict Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer
“SAN ANTONIO – Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared...
Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH
SAN ANTONIO – Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease...
Circulating Tumor Cell Count Could Help Choose Treatment for Metastatic Breast Cancer Patients
SAN ANTONIO – Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment...